Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors <scp>PRPF8</scp> and <scp>RBMX</scp> as novel candidate actionable targets
Emilia Alors‐Pérez(Instituto de Salud Carlos III), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Iranzu González‐Borja(Universidad Pública de Navarra (UPNA)), Andrea Mafficini(University of Verona), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), María Trinidad Moreno-Montilla(Instituto Maimónides de Investigación Biomédica de Córdoba), Álvaro Arjona‐Sánchez(Instituto Maimónides de Investigación Biomédica de Córdoba), Juan M. Jiménez‐Vacas(Instituto de Salud Carlos III), Sergio Pedraza‐Arévalo(Instituto Maimónides de Investigación Biomédica de Córdoba), Víctor García‐Vioque(Instituto Maimónides de Investigación Biomédica de Córdoba), Rita T. Lawlor(University of Verona), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Claudio Luchini(University of Verona), Juan Manuel Sánchez‐Hidalgo(Instituto Maimónides de Investigación Biomédica de Córdoba), Ricardo Blázquez‐Encinas(Instituto Maimónides de Investigación Biomédica de Córdoba), Antonio Romero‐Ruíz(Instituto Maimónides de Investigación Biomédica de Córdoba), A. Viúdez(Universidad Pública de Navarra (UPNA)), Aldo Scarpa(University of Verona), Marina Sánchez‐Frías(Instituto Maimónides de Investigación Biomédica de Córdoba), Raúl M. Luque(Instituto de Salud Carlos III)
Cited by 8
Related Papers
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach
|Annals of Oncology|2019|1k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390